You have 9 free searches left this month | for more free features.

CART%20Cell%20Therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

Completed
  • Leukemia
  • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 19, 2023

    Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy Trial (ultra-fraction radiotherapy)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +3 more
    • ultra-fraction radiotherapy
    • (no location specified)
    Aug 22, 2022

    Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

    Not yet recruiting
    • Kidney Transplant
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Sep 20, 2023

    Multiple Myeloma Trial in United States (Talquetamab)

    Recruiting
    • Multiple Myeloma
    • Basking Ridge, New Jersey
    • +6 more
    Sep 27, 2023

    Ovarian Cancer Trial in Shanghai (anti- MESO CAR-T cells, Fludarabine, Cyclophosphamide)

    Recruiting
    • Ovarian Cancer
    • anti- MESO CAR-T cells
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai 6th People's Hospital
    Aug 9, 2021

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

    Recruiting
    • Multiple Myeloma
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 12, 2023

    B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma Trial in Philadelphia (Autologous, humanized anti-CD22 CAR

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B Lineage Lymphoblastic Lymphoma
    • Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
    • Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jan 25, 2023

    Multiple Myeloma Trial in Philadelphia (BCMA CART + huCART19, CART BCMA or CART BCMA + huCART19, Single-dose infusion of CART

    Active, not recruiting
    • Multiple Myeloma
    • BCMA CART + huCART19
    • +2 more
    • Philadelphia, Pennsylvania
      Univ. of Pennsylvania
    Jul 11, 2022

    ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jun 7, 2021

      SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy

      Recruiting
      • Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
      • COVID-19 serology IgG
      • Detroit, Michigan
        Henry Ford Health System
      Jul 19, 2022

      Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

      Not yet recruiting
      • Leukemia, Acute Lymphoblastic
      • Lymphoma, Non-Hodgkin
      • CART-19
      • Ribeirao Preto, Sao Paulo, Brazil
        Ribeirao Preto School of Medicine, University of Sao Paulo
      Oct 23, 2023

      CART Therapy Trial in Madrid

      Completed
      • CART Therapy
        • Madrid, Spain
          Angel Cedillo
        May 26, 2022

        B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,

        Recruiting
        • B-Cell Non-Hodgkin Lymphoma
        • +7 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Dec 9, 2022

        Leukemia, T Cell Trial in Beijing (CD7 CART)

        Recruiting
        • Leukemia, T Cell
        • CD7 CART
        • Beijing, Hebei, China
          He bei Yan da Lu dao pei Hospital
        May 24, 2022

        DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • +6 more
        • Axicabtagene Ciloleucel
        • +10 more
        • (no location specified)
        Jan 13, 2023

        Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

        Recruiting
        • Plasma Cell Leukemia
        • anti-BCMA CAR-T
        • Tianjin, China
          Institute of Hematology and Blood Diseases Hospital Chinese Acad
        May 13, 2023

        Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Chapel Hill, Houston (CAR.CD30 T cells)

        Active, not recruiting
        • Non-Hodgkin's Lymphoma
        • Hodgkin's Lymphoma
        • CAR.CD30 T cells
        • Chapel Hill, North Carolina
        • +2 more
        Mar 16, 2022

        Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

        Not yet recruiting
        • Recurrent Multiple Myeloma
        • Refractory Multiple Myeloma
        • Bone Marrow Aspiration
        • +10 more
        • Los Angeles, California
          Melanie Ayala Ceja
        Jul 10, 2023

        Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Suzhou (CD19/22 CART, Tislelizumab)

        Unknown status
        • Relapsed Non Hodgkin Lymphoma
        • Refractory Non-Hodgkin Lymphoma
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Jul 30, 2021

        T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

        Not yet recruiting
        • T-Cell Non-Hodgkin Lymphoma
        • +14 more
        • WU-CART-007
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jan 17, 2023

        Multiple Myeloma Trial in Boston, Milwaukee (CART-ddBCMA)

        Not yet recruiting
        • Multiple Myeloma
        • CART-ddBCMA
        • Boston, Massachusetts
        • +1 more
        Jul 7, 2022

        Study for Patients Treat With WU-CART-007

        Enrolling by invitation
        • T-cell Acute Lymphoblastic Leukemia
        • T-cell Lymphoblastic Lymphoma
        • Genetic: WU-CART-007
        • Saint Louis, Missouri
          Washington University
        Aug 18, 2022

        Multiple Myeloma Trial in Philadelphia (CART-19 cells)

        Terminated
        • Multiple Myeloma
        • CART-19 cells
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Jan 4, 2023

        Leukemia, Lymphoma Trial in Beijing (Anti-CD22-CAR-transduced T cells)

        Unknown status
        • Leukemia
        • Lymphoma
        • Anti-CD22-CAR-transduced T cells
        • Beijing, Beijing, China
          Fengtai District
        Feb 6, 2021